These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 17307847)
1. Inactivation of the mismatch repair system in Pseudomonas aeruginosa attenuates virulence but favors persistence of oropharyngeal colonization in cystic fibrosis mice. Mena A; Maciá MD; Borrell N; Moya B; de Francisco T; Pérez JL; Oliver A J Bacteriol; 2007 May; 189(9):3665-8. PubMed ID: 17307847 [TBL] [Abstract][Full Text] [Related]
2. Biological cost of hypermutation in Pseudomonas aeruginosa strains from patients with cystic fibrosis. Montanari S; Oliver A; Salerno P; Mena A; Bertoni G; Tümmler B; Cariani L; Conese M; Döring G; Bragonzi A Microbiology (Reading); 2007 May; 153(Pt 5):1445-1454. PubMed ID: 17464058 [TBL] [Abstract][Full Text] [Related]
3. Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance. Oliver A; Mena A Clin Microbiol Infect; 2010 Jul; 16(7):798-808. PubMed ID: 20880409 [TBL] [Abstract][Full Text] [Related]
4. The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants. Oliver A; Baquero F; Blázquez J Mol Microbiol; 2002 Mar; 43(6):1641-50. PubMed ID: 11952911 [TBL] [Abstract][Full Text] [Related]
5. Evolution and adaptation in Pseudomonas aeruginosa biofilms driven by mismatch repair system-deficient mutators. Luján AM; Maciá MD; Yang L; Molin S; Oliver A; Smania AM PLoS One; 2011; 6(11):e27842. PubMed ID: 22114708 [TBL] [Abstract][Full Text] [Related]
6. Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation. Mena A; Smith EE; Burns JL; Speert DP; Moskowitz SM; Perez JL; Oliver A J Bacteriol; 2008 Dec; 190(24):7910-7. PubMed ID: 18849421 [TBL] [Abstract][Full Text] [Related]
7. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. Bragonzi A; Paroni M; Nonis A; Cramer N; Montanari S; Rejman J; Di Serio C; Döring G; Tümmler B Am J Respir Crit Care Med; 2009 Jul; 180(2):138-45. PubMed ID: 19423715 [TBL] [Abstract][Full Text] [Related]
8. Sequence variability and functional analysis of MutS of hypermutable Pseudomonas aeruginosa cystic fibrosis isolates. Hogardt M; Schubert S; Adler K; Götzfried M; Heesemann J Int J Med Microbiol; 2006 Aug; 296(4-5):313-20. PubMed ID: 16542874 [TBL] [Abstract][Full Text] [Related]
10. Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in Pseudomonas aeruginosa from cystic fibrosis chronic airways infections. Feliziani S; Luján AM; Moyano AJ; Sola C; Bocco JL; Montanaro P; Canigia LF; Argaraña CE; Smania AM PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844762 [TBL] [Abstract][Full Text] [Related]
11. The Small RNA ErsA Plays a Role in the Regulatory Network of Pseudomonas aeruginosa Pathogenicity in Airway Infections. Ferrara S; Rossi A; Ranucci S; De Fino I; Bragonzi A; Cigana C; Bertoni G mSphere; 2020 Oct; 5(5):. PubMed ID: 33055260 [TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis-niche adaptation of Pseudomonas aeruginosa reduces virulence in multiple infection hosts. Lorè NI; Cigana C; De Fino I; Riva C; Juhas M; Schwager S; Eberl L; Bragonzi A PLoS One; 2012; 7(4):e35648. PubMed ID: 22558188 [TBL] [Abstract][Full Text] [Related]
13. Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections. Maciá MD; Blanquer D; Togores B; Sauleda J; Pérez JL; Oliver A Antimicrob Agents Chemother; 2005 Aug; 49(8):3382-6. PubMed ID: 16048951 [TBL] [Abstract][Full Text] [Related]
18. Coexistence and within-host evolution of diversified lineages of hypermutable Pseudomonas aeruginosa in long-term cystic fibrosis infections. Feliziani S; Marvig RL; Luján AM; Moyano AJ; Di Rienzo JA; Krogh Johansen H; Molin S; Smania AM PLoS Genet; 2014 Oct; 10(10):e1004651. PubMed ID: 25330091 [TBL] [Abstract][Full Text] [Related]
19. Antibiotic pressure compensates the biological cost associated with Pseudomonas aeruginosa hypermutable phenotypes in vitro and in a murine model of chronic airways infection. Alcalá-Franco B; Montanari S; Cigana C; Bertoni G; Oliver A; Bragonzi A J Antimicrob Chemother; 2012 Apr; 67(4):962-9. PubMed ID: 22294647 [TBL] [Abstract][Full Text] [Related]
20. Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factors. Deretic V; Schurr MJ; Boucher JC; Martin DW J Bacteriol; 1994 May; 176(10):2773-80. PubMed ID: 8188579 [No Abstract] [Full Text] [Related] [Next] [New Search]